Note: The impact score or impact index shown here is equivalent to the average number of times documents published in a journal/conference in the past two years have been cited in the current year (i.e., Cites / Doc. (2 years)). It is based on Scopus data and can be a little higher or different compared to the impact factor (IF) produced by Journal Citation Report. Please refer to the Web of Science data source to check the exact journal impact factor ™ (Thomson Reuters) metric.
|Subject Area, Categories, Scope||Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4)|
|SCImago Journal Rank (SJR)||0.110|
PharmacoVigilance Review is a journal covering the technologies/fields/categories related to Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4). It is published by Euromed Communications. The overall rank of PharmacoVigilance Review is 25370. According to SCImago Journal Rank (SJR), this journal is ranked 0.110. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come. SJR acts as an alternative to the Journal Impact Factor (or an average number of citations received in last 2 years). This journal has an h-index of 2. The best quartile for this journal is Q4.
The ISSN of PharmacoVigilance Review journal is 17526752. An International Standard Serial Number (ISSN) is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic. PharmacoVigilance Review is cited by a total of 0 articles during the last 3 years (Preceding 2022).
The impact score (IS) 2022 of PharmacoVigilance Review is 0.00, which is computed in 2023 as per its definition. The impact score (IS), also denoted as Journal impact score (JIS), of an academic journal is a measure of the yearly average number of citations to recent articles published in that journal. It is based on Scopus data.
IS 2022 of PharmacoVigilance Review is 0.00. If the same upward trend persists, impact score may rise in 2023 as well.
|Year||Impact Score (IS)|
PharmacoVigilance Review has an h-index of 2. It means 2 articles of this journal have more than 2 number of citations. The h-index is a way of measuring the productivity and citation impact of the publications. The h-index is defined as the maximum value of h such that the given journal/author has published h papers that have each been cited at least h number of times.
The ISSN of PharmacoVigilance Review is 17526752. ISSN stands for International Standard Serial Number.
An ISSN is a unique code of 8 digits. It is used for the recognition of journals, newspapers, periodicals, and magazines in all kind of forms, be it print-media or electronic.
The overall rank of PharmacoVigilance Review is 25370. According to SCImago Journal Rank (SJR), this journal is ranked 0.110. SCImago Journal Rank is an indicator, which measures the scientific influence of journals. It considers the number of citations received by a journal and the importance of the journals from where these citations come.
PharmacoVigilance Review is published by Euromed Communications. It's publishing house is located in United Kingdom. Coverage history of this journal is as following: 2010-2019. The organization or individual who handles the printing and distribution of printed or digital publications is known as Publisher.
Visit the official website of the journal/conference to check the further details about the call for papers.
The IS0 4 standard abbreviation of PharmacoVigilance Review is PharmacoVigil. Rev.. This abbreviation ('PharmacoVigil. Rev.') is well recommended and approved for the purpose of indexing, abstraction, referencing and citing goals. It meets all the essential criteria of ISO 4 standard.
ISO 4 (International Organization for Standardization 4) is an international standard that defines a uniform and consistent system for abbreviating serial publication titles and journals.
If your research field is/are related to Health Policy (Q4); Pharmacology, Toxicology and Pharmaceutics (miscellaneous) (Q4), then please visit the official website of this journal.
The acceptance rate/percentage of any academic journal/conference depends upon many parameters. Some of the critical parameters are listed below.
It is essential to understand that the acceptance rate/rejection rate of papers varies among journals. Some Journals considers all the manuscripts submissions as a basis of acceptance rate computation. On the other hand, few consider the only manuscripts sent for peer review or few even not bother about the accurate maintenance of total submissions. Hence, it can provide a rough estimation only.
The best way to find out the acceptance rate is to reach out to the associated editor or to check the official website of the Journal/Conference.
The latest impact index of the PharmacoVigilance Review is 0.00. It's evaluated in the year 2022. The highest and the lowest impact index or impact score of this journal are 0.17 (2020) and 0.00 (2022), respectively, in the last 9 years. Moreover, its average IS is 0.04 in the previous 9 years.
The PharmacoVigilance Review has an SJR (SCImago Journal Rank) of 0.110, according to the latest data. It is computed in the year 2023. In the past 9 years, this journal has recorded a range of SJR, with the highest being 0.144 in 2021 and the lowest being 0.101 in 2019. Furthermore, the average SJR of the PharmacoVigilance Review over the previous 9-year period stands at 0.04.
The latest h-index of the PharmacoVigilance Review is 2.
The PharmacoVigilance Review is published by the Euromed Communications, with its country of publication being the United Kingdom.
The PharmacoVigilance Review is currently ranked 25370 out of 27955 Journals, Conferences, and Book Series in the latest ranking. Over the course of the last 9 years, this journal has experienced varying rankings, reaching its highest position of 21502 in 2021 and its lowest position of 30833 in 2017.
The standard ISO4 abbreviation for the PharmacoVigilance Review is PharmacoVigil. Rev..
PharmacoVigilance Review is classified as a journal that the Euromed Communications publishes.
The PharmacoVigilance Review encompasses the following areas:
For a more comprehensive understanding of its scope, check the official website of this journal.
The PharmacoVigilance Review is assigned the following International Standard Serial Numbers (ISSN): 17526752.
The best quartile for the PharmacoVigilance Review is Q4 (2022).
The PharmacoVigilance Review coverage history can be summarized as follows: 2010-2019.
|Journal/Conference/Workshop/Book Title||Type||Ranking||Publisher||h-index||Impact Score|
|Proceedings of the International Symposium on Power Semiconductor Devices and ICs||conference and proceedings||7015||49||2.14|
|Criminal Justice Review||journal||8738||SAGE Publications Inc.||41||1.30|
|Journal of International Financial Management and Accounting||journal||6179||Wiley-Blackwell Publishing Ltd||42||6.09|
|Journal of Supply Chain Management||journal||378||Wiley-Blackwell||104||12.58|
|Journal of Classical Sociology||journal||13766||SAGE Publications Ltd||27||0.83|
|Journal, Indian Academy of Clinical Medicine||journal||24608||Indian Academy of Clinical Medicine||16||0.06|
|Journal of Education and Work||journal||9268||Brill Academic Publishers||43||1.93|
|Studies in Continuing Education||journal||6011||Routledge||38||2.81|
|Educational Measurement: Issues and Practice||journal||4494||Wiley-Blackwell Publishing Ltd||59||1.53|
|Population Review||journal||17841||Sociological Demography Press||13||0.73|
|Year||Impact Score (IS)|